Clinical Trial Update: Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

Phase I study update reporting the completion of a trial evaluating SHR-2002 in combination with SHR-1316 in patients with advanced malignant tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SHR-1316
• SHR-2002

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: COMPLETED